A new form of drug drastically improves survival rates of younger women with the most common type of breast cancer, researchers said on Saturday, citing the results of an international clinical trial.
The findings, presented at the annual meeting of the American Society of Clinical Oncology in Chicago, showed that the addition of cell-cycle inhibitor ribociclib increased survival rates to 70 percent after three-and-a-half years.
The mortality rate was 29 percent less than when patients, all under 59 and pre-menopausal, were randomly assigned a placebo.
Lead author Sara Hurvitz said the study focused on a form of breast cancer that is fueled by the hormone estrogen and which accounts for two-thirds of all cases among younger women.
It is generally treated by therapies that block the hormone’s production.
“You actually can get synergy, or a better response, better cancer kill, by adding one of these cell-cycle inhibitors” on top of the hormone blocking therapy, Hurvitz said.
The drug works by inhibiting the activity of cancer-cell promoting enzymes. The treatment is less toxic than traditional chemotherapy, because it more selectively targets cancerous cells, blocking their ability to multiply.
Though advanced breast cancer is less common among younger women, its incidence grew 2 percent per year in the US between 1978 and 2008 for women aged 20 to 39, a previous study showed.
The new trial, which looked at more than 670 cases, included only women who had advanced cancer — stage four — for which they had not received prior hormone-blocking therapy.
“These are patients who tend to be diagnosed later, at a later stage in their disease, because we don’t have great screening modalities for young women,” Hurvitz said.
In addition, patients who develop breast cancer early tend to have more complex cases.
A pill is administered daily for 21 days followed by seven days off to allow the body time to recover, since two-thirds of patients have a moderate to severe drop in white cell count.
Jamie Bennett, a spokeswoman for Novartis, which markets the drug under the brand name Kisqali and funded the research, said it cost US$12,553 for a 28-day dose.
There is no cure for metastatic breast cancer and the majority of the women on the drug will require some form of therapy for the rest of their lives.
Oncologist Harold Burstein of the Dana-Farber Cancer Institute in Boston, who was not involved in the research, said it was “an important study,” having established that the use of the drug “translates into a significant survival benefit for women.”
“Hopefully, these data will enable access for this product for more women around the world, particularly in healthcare systems which assess value rigorously as part of their decisions for national access to drugs,” Burstein added.
A missing fingertip offers a clue to Mako Nishimura’s criminal past as one of Japan’s few female yakuza, but after clawing her way out of the underworld, she now spends her days helping other retired gangsters reintegrate into society. The multibillion-dollar yakuza organized crime network has long ruled over Japan’s drug rings, illicit gambling dens and sex trade. In the past few years, the empire has started to crumble as members have dwindled and laws targeting mafia are tightened. An intensifying police crackdown has shrunk yakuza forces nationwide, with their numbers dipping below 20,000 last year for the first time since records
EXTRADITION FEARS: The legislative changes come five years after a treaty was suspended in response to the territory’s crackdown on democracy advocates Exiled Hong Kong dissidents said they fear UK government plans to restart some extraditions with the territory could put them in greater danger, adding that Hong Kong authorities would use any pretext to pursue them. An amendment to UK extradition laws was passed on Tuesday. It came more than five years after the UK and several other countries suspended extradition treaties with Hong Kong in response to a government crackdown on the democracy movement and its imposition of a National Security Law. The British Home Office said that the suspension of the treaty made all extraditions with Hong Kong impossible “even if
CAUSE UNKNOWN: Weather and runway conditions were suitable for flight operations at the time of the accident, and no distress signal was sent, authorities said A cargo aircraft skidded off the runway into the sea at Hong Kong International Airport early yesterday, killing two ground crew in a patrol car, in one of the worst accidents in the airport’s 27-year history. The incident occurred at about 3:50am, when the plane is suspected to have lost control upon landing, veering off the runway and crashing through a fence, the Airport Authority Hong Kong said. The jet hit a security patrol car on the perimeter road outside the runway zone, which then fell into the water, it said in a statement. The four crew members on the plane, which
Japan’s ruling Liberal Democratic Party (LDP) and its junior partner yesterday signed a coalition deal, paving the way for Sanae Takaichi to become the nation’s first female prime minister. The 11th-hour agreement with the Japan Innovation Party (JIP) came just a day before the lower house was due to vote on Takaichi’s appointment as the fifth prime minister in as many years. If she wins, she will take office the same day. “I’m very much looking forward to working with you on efforts to make Japan’s economy stronger, and to reshape Japan as a country that can be responsible for future generations,”